Categories: World

BRIEF-CSPC Pharmaceutical Says SYH2061 Injection Obtains Clinical Trial Approval In China

Published by TSG Syndication

Oct 24 (Reuters) - CSPC Pharmaceutical Group Ltd : * SYH2061 INJECTION OBTAINS CLINICAL TRIAL APPROVAL IN CHINA Further company coverage: (The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
TSG Syndication
Published by TSG Syndication